18.02.2017 Views

VA/DoD CLINICAL PRACTICE GUIDELINE FOR OPIOID THERAPY FOR CHRONIC PAIN

2lfFhbO

2lfFhbO

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>VA</strong>/<strong>DoD</strong> Clinical Practice Guideline for Opioid Therapy for Chronic Pain<br />

Table E-3. Key Question Specific Comparators<br />

Question<br />

Comparators<br />

1 Patients without a co-occurring medical or mental health condition on LOT<br />

2 Comparison groups that vary by LOT dosage and length of opioid use, other factors<br />

3<br />

4<br />

5<br />

No OT (including placebo) or other pain management strategies<br />

Other modalities:<br />

• Non-opioid medications (e.g., non-steroidal including compounded topical preparations)<br />

• Physical interventions (e.g., physical therapy, active/passive exercise, ultrasound stimulation,<br />

chiropractic, osteopathic manipulation therapy)<br />

• Behavioral/mental health interventions EXAMPLES:<br />

• CBT<br />

• Dialectical behavior therapy (DBT)<br />

• Mindfulness<br />

• Acceptance and commitment therapy (ACT)<br />

• Complementary and alternative interventions EXAMPLES:<br />

• Acupuncture<br />

• Chiropractic interventions<br />

No OT (including placebo) or other pain management strategies<br />

Other modalities:<br />

• Non-opioid medications (e.g., non-steroidal including compounded topical preparations)<br />

• Physical interventions (e.g., physical therapy, active/passive exercise, ultrasound stimulation,<br />

chiropractic, osteopathic manipulation therapy)<br />

• Behavioral/ mental health interventions (e.g., CBT, ACT, mindfulness, DBT)<br />

• Complementary and alternative interventions<br />

Long-acting opioid drugs or combination short and long-acting drugs (See list)<br />

Other route of administration/delivery alternatives<br />

Non abuse-deterrent formulations<br />

Other opioids<br />

No use of buprenorphine<br />

No use of methadone<br />

6 Opioid therapy alone<br />

7 No mitigation strategy or other mitigation strategy<br />

8 No treatment for OUD or other treatment for OUD<br />

9 Different tapering strategy or schedule<br />

d. Outcomes<br />

For the treatment and management questions (KQ 3–9), the following outcomes were of interest in the<br />

systematic review:<br />

• Pain relief<br />

• Quality of life<br />

• Cognitive/functional status<br />

• Mortality<br />

• Opioid abuse/misuse<br />

February 2017 Page 110 of 192

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!